NASDAQ · Financial Statements
ImmuCell Corporation (ICCC) Financial Statements
$9.80
NASDAQ: ICCC
Market Cap $88.66M
ImmuCell Corporation most recently reported annual revenue of $28.0M, a net loss of $1.0M. Revenue grew at an average annual rate of 13.3% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.